cfMethyl-Seq cancer detection primary paper
2022 version of record, corrected competing-interest disclosure in 2024 · Peer-reviewed
What this source contributed
Records in this release that cite this source. A record can cite several sources.
Results
Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.
| Model or configuration | Metric | Value | Dataset | Evaluation |
|---|---|---|---|---|
| cfMethyl-Seq stacked ensemble (2022) | Sensitivity at 97.9% specificity | 80.7 percent | cfMethyl-Seq 408 QC-passing plasma samples | cfMethyl-Seq all-stage cancer detection |
Claims
Statements this source supports, each with where in the source it was checked.
- Relevance of cfMethyl-Seq random-split four-cancer detection to "Select a plasma ctDNA methylation detection workflow": Assessed by cfMethyl-Seq random-split four-cancer detection (amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/)
Models, benchmarks and other records
Configurations (1)
Protocols (1)
Datasets (1)
Evaluations (1)
Use cases (1)
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
24 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Archive note Unchanged gzip mtime=0; internal source audit. Public hosting/reuse requires respecting source licence. Source metadata | cfMethyl-Seq cancer detection primary paper No field-specific location recorded Version: 2022 version of record, corrected competing-interest disclosure in 2024 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Archive sha256 8df9f408977408680f56c650f9d4b60c18477540b9f78621a0c24c2b54710d9a Source metadata | cfMethyl-Seq cancer detection primary paper No field-specific location recorded Version: 2022 version of record, corrected competing-interest disclosure in 2024 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact SHA-256 6b299962d4cb5684ef98e7f765df16eb19c7833eca66fc5b0cbdc6aa9be29eca Source metadata | cfMethyl-Seq cancer detection primary paper No field-specific location recorded Version: 2022 version of record, corrected competing-interest disclosure in 2024 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact url https://www.ebi.ac.uk/europepmc/webservices/rest/PMC9522828/fullTextXML Source metadata | cfMethyl-Seq cancer detection primary paper No field-specific location recorded Version: 2022 version of record, corrected competing-interest disclosure in 2024 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Doi 10.1038/s41467-022-32995-6 Source metadata | cfMethyl-Seq cancer detection primary paper No field-specific location recorded Version: 2022 version of record, corrected competing-interest disclosure in 2024 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Licence CC-BY-4.0 Source metadata | cfMethyl-Seq cancer detection primary paper No field-specific location recorded Version: 2022 version of record, corrected competing-interest disclosure in 2024 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Media type application/xml Source metadata | cfMethyl-Seq cancer detection primary paper No field-specific location recorded Version: 2022 version of record, corrected competing-interest disclosure in 2024 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Original artifact sha256 6b299962d4cb5684ef98e7f765df16eb19c7833eca66fc5b0cbdc6aa9be29eca Source metadata | cfMethyl-Seq cancer detection primary paper No field-specific location recorded Version: 2022 version of record, corrected competing-interest disclosure in 2024 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Publication status peer_reviewed Source metadata | cfMethyl-Seq cancer detection primary paper No field-specific location recorded Version: 2022 version of record, corrected competing-interest disclosure in 2024 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Retrieved at 2026-10-07T12:24:42.995810+00:00 Source metadata | cfMethyl-Seq cancer detection primary paper No field-specific location recorded Version: 2022 version of record, corrected competing-interest disclosure in 2024 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
Scoped author-reported evidence candidate; no clinical recommendation.
Technical metadata and extraction receipts
Stable ID: amp-source-cfmethyl
- areas
- dna-genomes
- contexts
- clinical_research
- archive note
- Unchanged gzip mtime=0; internal source audit. Public hosting/reuse requires respecting source licence.
- archive sha256
- 8df9f408977408680f56c650f9d4b60c18477540b9f78621a0c24c2b54710d9a
- artifact sha256
- 6b299962d4cb5684ef98e7f765df16eb19c7833eca66fc5b0cbdc6aa9be29eca
- artifact url
- https://www.ebi.ac.uk/europepmc/webservices/rest/PMC9522828/fullTextXML
- doi
- 10.1038/s41467-022-32995-6
- licence
- CC-BY-4.0
- media type
- application/xml
- original artifact sha256
- 6b299962d4cb5684ef98e7f765df16eb19c7833eca66fc5b0cbdc6aa9be29eca
- publication status
- peer_reviewed
- retrieved at
- 2026-10-07T12:24:42.995810+00:00
- review artifact
- data/omics/amp-coverage-20261007/methylation-cnv-operations/artifacts/cfmethyl.xml.gz
- review artifact format
- original_source_artifact
- review artifact matches original artifact sha256
- true
- url
- https://www.ebi.ac.uk/europepmc/webservices/rest/PMC9522828/fullTextXML
- version
- 2022 version of record, corrected competing-interest disclosure in 2024
- source locator
- Full primary source bytes; per-result exact locators below